Purchases and Sales Made in Q2 2024 in 4 D Molecular Therapeutics, Inc. (FDMT)
This table provides information about the institutional ownership of 4 D Molecular Therapeutics, Inc. (FDMT) during Q2 2024. The information is specifically focused on institutions that hold shares of 4D Molecular Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 07, 2024
Q2 2024
|
Daiwa Securities Group Inc.
Tokyo, M0 |
SELL
|
- |
-5.39K- 96.7% |
$113K - $162K
|
184
$843
|
|
Aug 13, 2024
Q2 2024
|
Profund Advisors LLC
|
SELL
|
- |
-6.48K- 26.52% |
$136K - $195K
|
18K
$82.3K
|
|
Aug 14, 2024
Q2 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-6.7K- 1.79% |
$140K - $201K
|
367K
$1.68M
|
|
Aug 12, 2024
Q2 2024
|
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
|
SELL
|
- |
-7.52K- 39.64% |
$157K - $226K
|
11.4K
$52.4K
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-15K- 17.04% |
$315K - $451K
|
73.2K
$335K
|
|
Jul 30, 2024
Q2 2024
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-18.6K- 92.32% |
$388K - $557K
|
1.54K
$7.07K
|
|
Aug 14, 2024
Q2 2024
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-19.4K- 5.09% |
$406K - $582K
|
362K
$1.66M
|
|
Aug 15, 2024
Q2 2024
|
Pdt Partners, LLC
New York, NY |
SELL
|
- |
-20.8K- 34.54% |
$435K - $623K
|
39.4K
$180K
|
|
Aug 14, 2024
Q2 2024
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-53.6K- 2.98% |
$1.12M - $1.61M
|
1.74M
$7.99M
|
|
Aug 12, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-56.8K- 14.1% |
$1.19M - $1.7M
|
346K
$1.58M
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-70.5K- 45.98% |
$1.48M - $2.11M
|
82.8K
$379K
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-71.9K- 27.89% |
$1.5M - $2.16M
|
186K
$851K
|
|
Aug 14, 2024
Q2 2024
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-88.5K- 44.9% |
$1.85M - $2.66M
|
109K
$497K
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-89.5K- 5.77% |
$1.87M - $2.69M
|
1.46M
$6.69M
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-89.5K- 5.77% |
$1.87M - $2.69M
|
1.46M
$6.69M
|
|
Aug 13, 2024
Q2 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-96.8K- 50.33% |
$2.03M - $2.91M
|
95.6K
$438K
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-99K- 4.54% |
$2.07M - $2.97M
|
2.08M
$9.52M
|
|
Aug 14, 2024
Q2 2024
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-188K- 14.9% |
$3.93M - $5.64M
|
1.07M
$4.92M
|
|
Aug 09, 2024
Q2 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-216K- 28.87% |
$4.53M - $6.49M
|
533K
$2.44M
|
|
Aug 14, 2024
Q2 2024
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
SELL
|
- |
-228K- 21.16% |
$4.77M - $6.85M
|
850K
$3.89M
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-307K- 82.06% |
$6.43M - $9.21M
|
67.1K
$308K
|
|
Aug 14, 2024
Q2 2024
|
Braidwell LP
Stamford, CT |
SELL
|
- |
-683K- 64.9% |
$14.3M - $20.5M
|
369K
$1.69M
|